Silo Pharma SILO
NASDAQ SILO
$1.50 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Silo Pharma (SILO) Income from Non-Controlling Interests (2022 - 2023)

Updated

Silo Pharma's Income from Non-Controlling Interests came in at $1.01 million for Q2 2023, up 11.8% from the prior quarter.

Analysis

Silo Pharma (SILO) Income from Non-Controlling Interests (2022 - 2023) Analysis & Trends

Over the trailing twelve months to Jun 30, 2023, Silo Pharma reported Income from Non-Controlling Interests of $4.57 million; for FY2022, it came in at $3.91 million.

  • The five-year range for quarterly Income from Non-Controlling Interests is $906,396 (Q1 2023) to $1.66 million (Q4 2022).
  • Business Quant data shows SILO's Income from Non-Controlling Interests at $906,396 (Q1 2023), $1.66 million (Q4 2022) and $983,246 (Q3 2022) in the three quarters before Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -2.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -7.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 1.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 10.00 Mn
10 Silo Pharma 1.69 Mn 1.69 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 1.01 Mn
Mar 31, 2023 906,396.00
Dec 31, 2022 1.66 Mn
Sep 30, 2022 983,246.00
API Access

Silo Pharma Income from Non-Controlling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=SILO&period=max&api_key=YOUR_API_KEY